Possible treatment of vitiligo lesions by particles isolated from stem cells in the laboratory
Phase 1
- Conditions
- vitiligo.Vitiligo
- Registration Number
- IRCT20240508061704N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Patients should have stable vitiligo
The patient's medical history should report the stability of the patient's disease in terms of the absence of new lesions during the last one year
Exclusion Criteria
Patients with more than 20% of the body surface involved with vitiligo
pregnant women
lactating women
patients with skin cancer
patients who have undergone other treatments for vitiligo in the past 3 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method